{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T10:01:39Z","timestamp":1775728899074,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12325-026-03505-7","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:38:30Z","timestamp":1771605510000},"page":"1689-1696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hospital-Treated Severe Hypoglycemia in Type 1 Diabetes in the US: A Retrospective Claims-Based Study of Diabetes-Related Complications and Direct Medical Costs"],"prefix":"10.1007","volume":"43","author":[{"given":"Adriana","family":"Boateng-Kuffour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keval","family":"Chandarana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamshi Ruthwik","family":"Anupindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Gaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitch","family":"DeKoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"11","key":"3505_CR1","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.2337\/dci21-0043","volume":"44","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589\u2013625. https:\/\/doi.org\/10.2337\/dci21-0043.","journal-title":"Diabetes Care"},{"key":"3505_CR2","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","volume":"48","author":"ADAPP Committee","year":"2025","unstructured":"Committee ADAPP. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142025. Diabetes Care. 2025;48:S181\u2013206. https:\/\/doi.org\/10.2337\/dc25-S009.","journal-title":"Diabetes Care"},{"issue":"5","key":"3505_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00125-020-05366-3","volume":"64","author":"SA Amiel","year":"2021","unstructured":"Amiel SA. The consequences of hypoglycaemia. Diabetologia. 2021;64(5):963\u201370. https:\/\/doi.org\/10.1007\/s00125-020-05366-3.","journal-title":"Diabetologia"},{"issue":"3","key":"3505_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ecl.2010.05.003","volume":"39","author":"PE Cryer","year":"2010","unstructured":"Cryer PE. Hypoglycemia in type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2010;39(3):641\u201354. https:\/\/doi.org\/10.1016\/j.ecl.2010.05.003.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"3505_CR5","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2337\/diacare.28.12.2948","volume":"28","author":"NN Zammitt","year":"2005","unstructured":"Zammitt NN, Frier BM. Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care. 2005;28(12):2948\u201361. https:\/\/doi.org\/10.2337\/diacare.28.12.2948.","journal-title":"Diabetes Care"},{"key":"3505_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/20420188251346260","author":"SA Berry","year":"2025","unstructured":"Berry SA, Goodman I, Heller S, Iqbal A. The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes. Ther Adv Endocrinol Metab. 2025. https:\/\/doi.org\/10.1177\/20420188251346260.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"3505_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/03007995.2017.1391079","volume":"34","author":"J Liu","year":"2018","unstructured":"Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J. The burden of severe hypoglycemia in type 1 diabetes. Curr Med Res Opin. 2018;34(1):171\u20137. https:\/\/doi.org\/10.1080\/03007995.2017.1391079.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"3505_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.18553\/jmcp.2021.27.3.385","volume":"27","author":"S Bajpai","year":"2021","unstructured":"Bajpai S, et al. Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States. J Manag Care Spec Pharm. 2021;27(3):385\u201391. https:\/\/doi.org\/10.18553\/jmcp.2021.27.3.385.","journal-title":"J Manag Care Spec Pharm"},{"issue":"4","key":"3505_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/dme.12844","volume":"33","author":"SR Heller","year":"2016","unstructured":"Heller SR, Frier BM, Hersl\u00f8v ML, Gundgaard J, Gough SCL. Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med. 2016;33(4):471\u20137. https:\/\/doi.org\/10.1111\/dme.12844.","journal-title":"Diabet Med"},{"issue":"4","key":"3505_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1177\/1932296816633233","volume":"10","author":"A Bronstone","year":"2016","unstructured":"Bronstone A, Graham C. The potential cost implications of averting severe hypoglycemic events requiring hospitalization in high-risk adults with type 1 diabetes using real-time continuous glucose monitoring. J Diabetes Sci Technol. 2016;10(4):905\u201313. https:\/\/doi.org\/10.1177\/1932296816633233.","journal-title":"J Diabetes Sci Technol"},{"key":"3505_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-8-4","volume":"8","author":"AA Ginde","year":"2008","unstructured":"Ginde AA, Blanc PG, Lieberman RM, Camargo CA Jr. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord. 2008;8:4. https:\/\/doi.org\/10.1186\/1472-6823-8-4.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"3505_CR12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2337\/dc12-0964","volume":"36","author":"M Klompas","year":"2013","unstructured":"Klompas M, Eggleston E, McVetta J, Lazarus R, Li L, Platt R. Automated detection and classification of type 1 versus type 2 diabetes using electronic health record data. Diabetes Care. 2013;36(4):914\u201321. https:\/\/doi.org\/10.2337\/dc12-0964.","journal-title":"Diabetes Care"},{"issue":"10","key":"3505_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/pds.4377","volume":"27","author":"EB Schroeder","year":"2018","unstructured":"Schroeder EB, Donahoo WT, Goodrich GK, Raebel MA. Validation of an algorithm for identifying type 1 diabetes in adults based on electronic health record data. Pharmacoepidemiol Drug Saf. 2018;27(10):1053\u20139. https:\/\/doi.org\/10.1002\/pds.4377.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3505_CR14","unstructured":"U.S. Bureau of Labor Statistics. \"Graphics for Economic News Releases. 12-month percentage change, Consumer Price Index, selected categories.\" https:\/\/www.bls.gov\/charts\/consumer-price-index\/consumer-price-index-by-category-line-chart.htm (accessed 12 January 2024, 2024)."},{"issue":"11","key":"3505_CR15","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.18553\/jmcp.2020.26.11.1399","volume":"26","author":"JC Simeone","year":"2020","unstructured":"Simeone JC, et al. Healthcare resource utilization and cost among patients with type 1 diabetes in the United States. J Manag Care Spec Pharm. 2020;26(11):1399\u2013410. https:\/\/doi.org\/10.18553\/jmcp.2020.26.11.1399.","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"3505_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2337\/db18-62-OR","volume":"67","author":"KR Mizokami-Stout","year":"2018","unstructured":"Mizokami-Stout KR, et al. Contemporary prevalence of diabetic neuropathy in type 1 diabetes (T1D)\u2014findings from the T1D Exchange. Diabetes Care. 2018;67(1):62. https:\/\/doi.org\/10.2337\/db18-62-OR.","journal-title":"Diabetes Care"},{"issue":"11","key":"3505_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1080\/13696998.2016.1201090","volume":"19","author":"M Sussman","year":"2016","unstructured":"Sussman M, et al. Economic impact of hypoglycemia among insulin-treated patients with diabetes. J Med Econ. 2016;19(11):1099\u2013106. https:\/\/doi.org\/10.1080\/13696998.2016.1201090.","journal-title":"J Med Econ"},{"key":"3505_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.107916","author":"L Shi","year":"2021","unstructured":"Shi L, Fonseca V, Childs B. Economic burden of diabetes-related hypoglycemia on patients, payors, and employers. J Diabetes Complications. 2021. https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.107916.","journal-title":"J Diabetes Complications"},{"issue":"4","key":"3505_CR19","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.37765\/ajmc.2025.89722","volume":"31","author":"M Kommareddi","year":"2025","unstructured":"Kommareddi M, Wherry K. Cost-effectiveness of the MiniMed 780G system for type 1 diabetes. Am J Manag Care. 2025;31(4):e79\u201386.","journal-title":"Am J Manag Care"},{"issue":"2","key":"3505_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/19322968211052081","volume":"17","author":"CR Vallarino","year":"2021","unstructured":"Vallarino CR, Wong-Jacobson SH, Benneyworth BD, Meadows ES. Costs and outcomes comparison of diabetes technology usage among people with type 1 or 2 diabetes using rapid-acting insulin. J Diabetes Sci Technol. 2021;17(2):439\u201348. https:\/\/doi.org\/10.1177\/19322968211052081.","journal-title":"J Diabetes Sci Technol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03505-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:14:20Z","timestamp":1775726060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3505"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03505-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adriana Boateng-Kuffour, Nanxin Li, Keval Chandarana, Liang Chen, and Beth Barber are employees of Vertex Pharmaceuticals Incorporated, and hold stocks at Vertex Pharmaceuticals Incorporated. Jason Gaglia is a consultant for Vertex Pharmaceuticals Incorporated and an employee of Joslin Diabetes Center. Vamshi Ruthwik Anupindi, Michael Hull, Xiaoyu Zhou and Mitch DeKoven were employees of IQVIA at the time this study was conducted, which received funding from Vertex Pharmaceuticals Incorporated for conducting this study. Michael Hull and Mitch DeKoven are no longer employed at IQVIA but have no new affiliations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study used de-identified, retrospective administrative claims data and did not involve the collection or use of identifiable personal information. As such, institutional review board (IRB) approval was not required in accordance with the Health Insurance Portability and Accountability Act (HIPAA). Necessary permissions were obtained from IQVIA to access and use the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}